Levetiracetam 90 H 31722 0538 12 Medication Summary
No separate FDA Medication Guide was found for this label. This summary is based on FDA/DailyMed prescribing information.
What is this medication?
This medication is described in FDA/DailyMed prescribing information. No separate FDA Medication Guide was found for this label. This summary is based on FDA/DailyMed prescribing information.
What is this medication used for?
Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older ( 1.1) Levetiracetam is indicated for adjunctive therapy for the treatment of: Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy ( 1.2) Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy ( 1.3)
What should I know before taking it?
Levetiracetam is contraindicated in patients with a hypersensitivity to levetiracetam .Reactions have included anaphylaxis and angioedema [see Warnings and Precautions (5.4)] .
What important warnings are listed?
Behavioral abnormalities including psychotic symptoms, suicidal ideation, irritability, and aggressive behavior have been observed; monitor patients for psychiatric signs and symptoms ( 5.1) Suicidal Behavior and Ideation: Monitor patients for new or worsening depression, suicidal thoughts/behavior, and/or unusual changes in mood or behavior ( 5.2) Monitor for somnolence and fatigue and advise patients not to drive or operate machinery until they have gained sufficient experience on levetiracetam ( 5.3) Serious Dermatological Reactions: Discontinue levetiracetam at the first sign of rash unless clearly not drug related. ( 5.5) Coordination Difficulties: Monitor for ataxia, abnormal gait,.
How is this medication usually taken?
Levetiracetam tablets USP, 250 mg are blue, film coated caplet shape tablets, scored on one side. Engraved "LVT" on left of the score line and "250" on the right, and engraved "TARO" on the other side. Levetiracetam tablets USP, 500 mg are yellow, film coated caplet shape tablets, scored on one side. Engraved "LVT" on left of the score line and "500" on the right, and engraved "TARO" on the other side. Levetiracetam tablets USP, 750 mg are peach, film coated caplet shape tablets, scored on one side. Engraved "LVT" on left of the score line and "750" on the right, and engraved "TARO" on the other side. Levetiracetam tablets USP, 1000 mg are white to off-white, film coated caplet shaped.
What side effects are listed?
The following adverse reactions are discussed in more details in other sections of labeling: Behavior Abnormalities and Psychotic Symptoms [see Warnings and Precautions (5.1)] Suicidal Behavior and Ideation [see Warnings and Precautions (5.2)] Somnolence and Fatigue [see Warnings and Precautions (5.3)] Anaphylaxis and Angioedema [see Warnings and Precautions (5.4)] Serious Dermatological Reactions [see Warnings and Precautions (5.5)] Coordination Difficulties [see Warnings and Precautions (5.6)] Hematologic Abnormalities [see Warnings and Precautions (5.8)] Increase in Blood Pressure [see Warnings and Precautions (5.9)]
What interactions are listed?
The FDA/DailyMed label should be reviewed for complete details.
Where can I find the official prescribing information?
Review the full prescribing information on DailyMed: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bf412e94-ca36-4da9-83d7-fb0f1323cf21
⚠️ Disclaimer
This summary is for educational purposes only and is not medical advice. Always consult your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine. Read full medical disclaimer.